Arcus Biosciences(RCUS) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update HAYWARD, Calif. – (BUSINESS WIRE) – May 8, 2024 – Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today reported financial results for the first quarter ended March 31, 2024, and provided a pipeline update on its clinical-stage investigational molecules – targeting TI ...